Article
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
14 Nov 2020
Abstract excerpt
Multiple sclerosis is an autoimmune disease of the CNS in which both genetic and environmental factors are involved. Genome-wide association studies revealed more than 200 risk loci, most of which harbour genes primarily expressed in immune cells. However, whether genetic differences are translated into cell-specific gene expression profiles and to what extent these are altered in patients with multiple sclerosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
